Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study

Jia M, Jia JK, Xu J, Xue HZ

Cancer Management and Research 2022, 14:2625-2638

Published Date: 2 September 2022